Literature DB >> 29967100

miR-155 Modulates Cockroach Allergen- and Oxidative Stress-Induced Cyclooxygenase-2 in Asthma.

Lipeng Qiu1,2, Yan Zhang1,3, Danh C Do1, Xia Ke1, Simin Zhang4, Kristin Lambert4, Shruthi Kumar1, Chengping Hu3, Yufeng Zhou5, Faoud T Ishmael6, Peisong Gao7.   

Abstract

Exposure to cockroach allergen is a strong risk factor for developing asthma. Asthma has been associated with allergen-induced airway epithelial damage and heightened oxidant stress. In this study, we investigated cockroach allergen-induced oxidative stress in airway epithelium and its underlying mechanisms. We found that cockroach extract (CRE) could induce reactive oxygen species (ROS) production, particularly mitochondrial-derived ROS, in human bronchial epithelial cells. We then used the RT2 Profiler PCR array and identified that cyclooxygenase-2 (COX-2) was the most significantly upregulated gene related to CRE-induced oxidative stress. miR-155, predicted to target COX-2, was increased in CRE-treated human bronchial epithelial cells, and was showed to regulate COX-2 expression. Moreover, miR-155 can bind COX-2, induce COX-2 reporter activity, and maintain mRNA stability. Furthermore, CRE-treated miR-155-/- mice showed reduced levels of ROS and COX-2 expression in lung tissues and PGE2 in bronchoalveolar lavage fluid compared with wild-type mice. These miR-155-/- mice also showed reduced lung inflammation and Th2/Th17 cytokines. In contrast, when miR-155-/- mice were transfected with adeno-associated virus carrying miR-155, the phenotypic changes in CRE-treated miR-155-/- mice were remarkably reversed, including ROS, COX-2 expression, lung inflammation, and Th2/Th17 cytokines. Importantly, plasma miR-155 levels were elevated in severe asthmatics when compared with nonasthmatics or mild-to-moderate asthmatics. These increased plasma miR-155 levels were also observed in asthmatics with cockroach allergy compared with those without cockroach allergy. Collectively, these findings suggest that COX-2 is a major gene related to cockroach allergen-induced oxidative stress and highlight a novel role of miR-155 in regulating the ROS-COX-2 axis in asthma.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29967100      PMCID: PMC6057819          DOI: 10.4049/jimmunol.1701167

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  76 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis.

Authors:  L Brussino; I Badiu; S Sciascia; M Bugiani; E Heffler; G Guida; A Malinovschi; C Bucca; G Rolla
Journal:  Clin Exp Allergy       Date:  2010-08-18       Impact factor: 5.018

3.  Differential microRNA epression in asthma and the role of miR-1248 in regulation of IL-5.

Authors:  Ronaldo Paolo L Panganiban; Mark H Pinkerton; Saumya Y Maru; Sarah J Jefferson; Alanna N Roff; Faoud T Ishmael
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

4.  MicroRNA-26a/-26b-COX-2-MIP-2 Loop Regulates Allergic Inflammation and Allergic Inflammation-promoted Enhanced Tumorigenic and Metastatic Potential of Cancer Cells.

Authors:  Yoojung Kwon; Youngmi Kim; Sangkyung Eom; Misun Kim; Deokbum Park; Hyuna Kim; Kyeonga Noh; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

5.  MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.

Authors:  Kristina Johansson; Carina Malmhäll; Patricia Ramos-Ramírez; Madeleine Rådinger
Journal:  J Allergy Clin Immunol       Date:  2016-08-01       Impact factor: 10.793

6.  Accentuated T helper type 2 airway response after allergen challenge in cyclooxygenase-1-/- but not cyclooxygenase-2-/- mice.

Authors:  Michelle A Carey; Dori R Germolec; J Alyce Bradbury; Rebecca A Gooch; Michael P Moorman; Gordon P Flake; Robert Langenbach; Darryl C Zeldin
Journal:  Am J Respir Crit Care Med       Date:  2003-03-05       Impact factor: 21.405

7.  MiR-1297 regulates the growth, migration and invasion of colorectal cancer cells by targeting cyclo-oxygenase-2.

Authors:  Pu Chen; Bei-Li Wang; Bai-Shen Pan; Wei Guo
Journal:  Asian Pac J Cancer Prev       Date:  2014

Review 8.  Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options.

Authors:  Ahmed Nadeem; Anbrin Masood; Nahid Siddiqui
Journal:  Ther Adv Respir Dis       Date:  2008-08       Impact factor: 4.031

9.  MicroRNA Expression Is Altered in an Ovalbumin-Induced Asthma Model and Targeting miR-155 with Antagomirs Reveals Cellular Specificity.

Authors:  Maximilian W Plank; Steven Maltby; Hock L Tay; Jessica Stewart; Fiona Eyers; Philip M Hansbro; Paul S Foster
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

10.  Cockroach protease allergen induces allergic airway inflammation via epithelial cell activation.

Authors:  Sagar L Kale; Komal Agrawal; Shailendra Nath Gaur; Naveen Arora
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

View more
  28 in total

1.  Ras homolog family member A/Rho-associated protein kinase 1 signaling modulates lineage commitment of mesenchymal stem cells in asthmatic patients through lymphoid enhancer-binding factor 1.

Authors:  Xia Ke; Danh C Do; Changjun Li; Yilin Zhao; Marian Kollarik; Qingling Fu; Mei Wan; Peisong Gao
Journal:  J Allergy Clin Immunol       Date:  2018-09-05       Impact factor: 10.793

2.  miR-511-3p protects against cockroach allergen-induced lung inflammation by antagonizing CCL2.

Authors:  Danh C Do; Jie Mu; Xia Ke; Karan Sachdeva; Zili Qin; Mei Wan; Faoud T Ishmael; Peisong Gao
Journal:  JCI Insight       Date:  2019-10-17

3.  MicroRNA Targets for Asthma Therapy.

Authors:  Sabrina C Ramelli; William T Gerthoffer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Circulating MicroRNAs and Treatment Response in Childhood Asthma.

Authors:  Jiang Li; Ronald Panganiban; Alvin T Kho; Michael J McGeachie; Leanna Farnam; Robert P Chase; Scott T Weiss; Quan Lu; Kelan G Tantisira
Journal:  Am J Respir Crit Care Med       Date:  2020-07-01       Impact factor: 21.405

5.  Engagement of MicroRNA-155 in Exaggerated Oxidative Stress Signal and TRPA1 in the Dorsal Horn of the Spinal Cord and Neuropathic Pain During Chemotherapeutic Oxaliplatin.

Authors:  Fenghua Miao; Rong Wang; Guozhen Cui; Xiaoguang Li; Ting Wang; Xue Li
Journal:  Neurotox Res       Date:  2019-04-23       Impact factor: 3.911

6.  Apremilast ameliorates IL-1α-induced dysfunction in epidermal stem cells.

Authors:  Yuxi Jia; Xiangru Chen; Jing Sun
Journal:  Aging (Albany NY)       Date:  2021-08-10       Impact factor: 5.955

Review 7.  Regulation of mRNA stability by RBPs and noncoding RNAs contributing to the pathogenicity of Th17 cells.

Authors:  Yiwei Zhang; Zhiyuan Wei; Hui Dong; Jian Zhou; Jizhao Yuan; Bing Ni; Yuzhang Wu; Chao Han; Yi Tian
Journal:  RNA Biol       Date:  2020-12-23       Impact factor: 4.652

Review 8.  MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases.

Authors:  Montserrat Climent; Giacomo Viggiani; Ya-Wen Chen; Gerald Coulis; Alessandra Castaldi
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

9.  CaMKII oxidation regulates cockroach allergen-induced mitophagy in asthma.

Authors:  Yan Zhang; Danh C Do; Xinyue Hu; Ji Wang; Yilin Zhao; Sumita Mishra; Xin Zhang; Mei Wan; Peisong Gao
Journal:  J Allergy Clin Immunol       Date:  2020-09-10       Impact factor: 10.793

10.  The Antioxidant Resveratrol Protects against Chondrocyte Apoptosis by Regulating the COX-2/NF-κB Pathway in Created Temporomandibular Osteoarthritis.

Authors:  Wen Li; Shiyu Hu; Xuepeng Chen; Jiejun Shi
Journal:  Biomed Res Int       Date:  2021-07-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.